Mangompit, Kimberly Shane P.

HRN: 29-23-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFUROXIME 1.5GM (VIAL)
07/01/2026
07/06/2026
IV
340mg
Q8H
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: